<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">30533</article-id><article-id pub-id-type="doi">10.22363/2313-0245-2022-26-1-9-33</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Physiology</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Физиология</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Carboxypeptidase A3 in the structure of the protease phenotype of mast cells: cytophysiological aspects</article-title><trans-title-group xml:lang="ru"><trans-title>Карбоксипептидаза А3 в структуре протеазного фенотипа тучных клеток: цитофизиологические аспекты</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8347-4556</contrib-id><name-alternatives><name xml:lang="en"><surname>Atiakshin</surname><given-names>Dmitrii A.</given-names></name><name xml:lang="ru"><surname>Атякшин</surname><given-names>Д. А.</given-names></name></name-alternatives><email>atyakshin-da@rudn.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0792-6012</contrib-id><name-alternatives><name xml:lang="en"><surname>Kostin</surname><given-names>Andrey A.</given-names></name><name xml:lang="ru"><surname>Костин</surname><given-names>А. А.</given-names></name></name-alternatives><email>atyakshin-da@rudn.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6667-0125</contrib-id><name-alternatives><name xml:lang="en"><surname>Trotsenko</surname><given-names>Ivan D.</given-names></name><name xml:lang="ru"><surname>Троценко</surname><given-names>И. Д.</given-names></name></name-alternatives><email>atyakshin-da@rudn.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9185-4578</contrib-id><name-alternatives><name xml:lang="en"><surname>Shishkina</surname><given-names>Victoria V.</given-names></name><name xml:lang="ru"><surname>Шишкина</surname><given-names>В. В.</given-names></name></name-alternatives><email>atyakshin-da@rudn.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6499-4855</contrib-id><name-alternatives><name xml:lang="en"><surname>Tiemann</surname><given-names>Markus</given-names></name><name xml:lang="ru"><surname>Тиманн</surname><given-names>М.</given-names></name></name-alternatives><email>atyakshin-da@rudn.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1142-7483</contrib-id><name-alternatives><name xml:lang="en"><surname>Buchwalow</surname><given-names>Igor B.</given-names></name><name xml:lang="ru"><surname>Бухвалов</surname><given-names>И. Б.</given-names></name></name-alternatives><email>atyakshin-da@rudn.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Voronezh N.N. Burdenko State Medical University</institution></aff><aff><institution xml:lang="ru">Воронежский государственный медицинский университет имени Н.Н. Бурденко</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Institute for Hematopathology</institution></aff><aff><institution xml:lang="ru">Институт гематопатологии</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-03-21" publication-format="electronic"><day>21</day><month>03</month><year>2022</year></pub-date><volume>26</volume><issue>1</issue><issue-title xml:lang="en">PHYSIOLOGY</issue-title><issue-title xml:lang="ru">ФИЗИОЛОГИЯ</issue-title><fpage>9</fpage><lpage>33</lpage><history><date date-type="received" iso-8601-date="2022-03-21"><day>21</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Atiakshin D.A., Kostin A.A., Trotsenko I.D., Shishkina V.V., Tiemann M., Buchwalow I.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Атякшин Д.А., Костин А.А., Троценко И.Д., Шишкина В.В., Тиманн М., Бухвалов И.Б.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Atiakshin D.A., Kostin A.A., Trotsenko I.D., Shishkina V.V., Tiemann M., Buchwalow I.B.</copyright-holder><copyright-holder xml:lang="ru">Атякшин Д.А., Костин А.А., Троценко И.Д., Шишкина В.В., Тиманн М., Бухвалов И.Б.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/30533">https://journals.rudn.ru/medicine/article/view/30533</self-uri><abstract xml:lang="en"><p style="text-align: justify;">Carboxypeptidase A3 (CPA3) is a specific protease of mast cells (MC) with variable expression and appears to be one of the preformed components of the secretome. CPA3 is involved in regulation of the state of a specifi tissue microenvironment and components of the integrative-buffer metabolic environment in adaptive and pathological processes; it affects implementation of the innate immunity, mechanisms of angiogenesis, processes of the extracellular matrix remodeling, etc. CPA3 identification using protocols of multiplex immunohistochemistry allows specifying details of the organ-specific mast cell population features, including the protease phenotype, mechanisms of biogenesis with cytoand histotopographic criteria, and features of secretory pathways. Numerous biological effects of CPA3, including participation in the regulation of the pulmonary parenchyma and systemic blood flow, in biogenesis and remodeling of the fibrous component of the extracellular matrix, in epigenetic reprogramming, determine the importance of fundamental investigation of the physiological activity of protease and its involvement in the implementation of pathological processes. Further studies will contribute to the detection of the translational value of the mast cell CPA3 expression features as a prognostic factor and a promising molecular target for treatment of socially significant diseases.</p></abstract><trans-abstract xml:lang="ru"><p style="text-align: justify;">Карбоксипептидаза А3 (СРА3) является специфической протеазой тучных клеток (ТК) с вариабельной экспрессией и входит в число преформированных компонентов секретома. CPA3 принимает участие в регуляции состояния специфического тканевого микроокружения и компонентов интегративно-буферной метаболической среды при адаптивных и патологических процессах, затрагивая реализацию врожденного иммунитета, механизмы ангиогенеза, процессы ремоделирования межклеточного матрикса и др. Идентификация СРА3 c помощью протоколов мультиплексной иммуногистохимии позволяет конкретизировать детали органоспецифических популяционных характеристик тучных клеток, включая протеазный фенотип, механизмы биогенеза с цитои гистотопографическими критериями, а также особенности секреторных путей. Многочисленные биологические эффекты СРА3, включая участие в регуляции состояния легочной паренхимы и системного кровотока, в биогенезе и ремоделировании волокнистого компонента внеклеточного матрикса, в эпигенетическом репрограммировании, определяют важность фундаментальных исследований физиологической активности протеазы и ее вовлеченности в реализацию патологических процессов. Дальнейшие исследования будут способствовать раскрытию трансляционного значения характеристик экспрессии CPA3 ТК в качестве прогностического фактора и перспективной молекулярной мишени терапии социально значимых заболеваний.</p></trans-abstract><kwd-group xml:lang="en"><kwd>carboxypeptidase A3</kwd><kwd>mast cells</kwd><kwd>secretome</kwd><kwd>granules</kwd><kwd>secretory pathways</kwd><kwd>specific tissue microenvironment</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>карбоксипептидаза А3</kwd><kwd>тучные клетки</kwd><kwd>секретом</kwd><kwd>гранулы</kwd><kwd>секреторные пути</kwd><kwd>специфическое тканевое микроокружение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Wernersson S, Pejler G. Mast cell secretory granules: armed for battle. Nat Rev Immunol. 2014;14(7):478-494.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Redegeld FA, Kumari S, Charles N, Blank U. Non-IgE mediated mast cell activation. Immunol Rev. 2018;282(1):87-113.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Aponte-López A, Muñoz-Cruz S. Mast Cells in the Tumor Microenvironment. Adv Exp Med Biol. 2020;1273:159-173. doi: 10.1007/978-3-030-49270-0_9</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Elieh Ali Komi D, Wöhrl S, Bielory L. Mast Cell Biology at Molecular Level: a Comprehensive Review. Clin Rev Allergy Immunol. 2020;58(3):342-365. doi: 10.1007/s12016-019-08769-2</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kolkhir P, Elieh-Ali-Komi D, Metz M, Siebenhaar F, Maurer M. Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases. Nat Rev Immunol. 2021. doi: 10.1038/ s41577-021-00622-y</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Elieh Ali Komi D, Kuebler WM. Significance of Mast Cell Formed Extracellular Traps in Microbial Defense. Clin Rev Allergy Immunol. 2021;22:1-20. doi: 10.1007/s12016-021-08861-6</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Dahlin JS, Maurer M, Metcalfe DD, Pejler G, SagiEisenberg R, Nilsson G. The ingenious mast cell: Contemporary insights into mast cell behavior and function. Allergy. 2021;77(16):83-99. doi: 10.1111/all.14881</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Paivandy A, Pejler G. Novel Strategies to Target Mast Cells in Disease. J Innate Immun. 2021;13(3):131-147. doi: 10.1159/000513582</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ribatti D, Annese T, Tamma R. Controversial role of mast cells in breast cancer tumor progression and angiogenesis. Clin Breast Cancer. 2021; S:1526-8209. doi: 10.1016/j.clbc.2021.08.010</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Crivellato E, Travan L, Ribatti D. The Phylogenetic Profile of Mast Cells. Mast Cells: Methods and Protocols. Methods in Molecular Biology. 2015;1220:11-27.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ribatti D. The development of human mast cells. An historical reappraisal. Exp. Cell Res. 2016; 342:210-215.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Valent P, Akin C, Hartmann K, Nilsson G, Reiter A, Hermine O, Sotlar K, Sperr WR, Escribano L, George TI, Kluin-Nelemans HC, Ustun C, Triggiani M, Brockow K, Gotlib J, Orfao A, Kovanen PT, Hadzijusufovic E, Sadovnik I, Horny HP, Arock M, Schwartz LB, Austen KF, Metcalfe DD, Galli SJ. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich’s visions to precision medicine concepts. Theranostics. 2020;10(23):10743-10768. doi: 10.7150/thno.46719</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Galli SJ, Tsai M, Marichal T, Tchougounova E, Reber LL, Pejler G. Approaches for analyzing the roles of mast cells and their proteases in vivo. Adv Immunol. 2015;126:45-127.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Mukai K, Mindy Tsai M. Saito H, Galli SJ. Mast cells as sources of cytokines, chemokines, and growth factors. Immunological Reviews. 2018;282:121-150.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Pejler G, Åbrink M, Ringvall M, Wernersson S. Mast cell proteases Adv Immunol. 2007;95:167-255.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Pejler G, Rönnberg E, Waern I, Wernersson S. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood. 2010;115(24):4981-4990.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Pejler G, Knight SD, Henningsson F, Wernersson S. Novel insights into the biological function of mast cell carboxypeptidase A. Trends Immunol. 2009;30(8):401-8. doi: 10.1016/j.it.2009.04.008</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Grujic M, Paivandy A, Gustafson AM, Thomsen AR, Öhrvik H, Pejler G. The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung. Oncotarget. 2017;8(15):25066-25079. doi: 10.18632/ oncotarget.15339</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Grujic M, Hellman L, Gustafson AM, Akula S, Melo FR, Pejler G. Protective role of mouse mast cell tryptase Mcpt6 in melanoma. Pigment Cell Melanoma Res. 2020;33(4):579-590. doi: 10.1111/pcmr.12859</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Siddhuraj P, Clausson CM, Sanden C, Alyamani M, Kadivar M, Marsal J, Wallengren J, Bjermer L, Erjefält JS. Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3. Cells. 2021;10(2):309. doi: 10.3390/cells10020309</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Akula S, Hellman L, Avilés FX, Wernersson S. Analysis of the mast cell expressed carboxypeptidase A3 and its structural and evolutionary relationship to other vertebrate carboxypeptidases. Dev Comp Immunol. 2021;127:104273. doi: 10.1016/j.dci.2021.104273</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lundequist A, Tchougounova E, Åbrink M, Pejler G. Cooperation between Mast Cell Carboxypeptidase A and the Chymase Mouse Mast Cell Protease 4 in the Formation and Degradation of Angiotensin II. J. Biol. Chem. 2004;279:32339-32344.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Schneider LA, Schlenner SM, Feyerabend TB, Wunderlin M, Rodewald HR. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med. 2007;204(11):2629-39. doi: 10.1084/jem.20071262</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Scandiuzzi L, Beghdadi W, Daugas E, Åbrink M, Tiwari N, Brochetta C, Claver J, Arouche N, Zang X, Pretolani M, et al. Mouse Mast Cell Protease-4 Deteriorates Renal Function by Contributing to Inflammation and Fibrosis in Immune Complex-Mediated Glomerulonephritis. J. Immunol. 2010;185:624-633.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Tanco S, Lorenzo J, Garcia-Pardo J, Degroeve S, Martens L, Aviles FX, Gevaert K, Van Damme P. Proteome-derived peptide libraries to study the substrate specifi profi of carboxypeptidases. Mol Cell Proteomics. 2013;12(8):2096-110. doi: 10.1074/mcp.M112.023234</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Xing D, Zhang R, Li S, Huang P, Luo C, Hei Z, Xia Z, Gan X. Pivotal role of mast cell carboxypeptidase A in mediating protection against small intestinal ischemia-reperfusion injury in rats after ischemic preconditioning. J Surg Res. 2014;192(1):177-86. doi: 10.1016/j.jss.2014.05.050</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Sverrild A, Bergqvist A, Baines KJ, Porsbjerg C, Andersson CK, Thomsen SF, Hoffmann HJ, Gibson P, Erjefalt JS, Backer V. Airway responsiveness to mannitol in asthma is associated with chymase-positive mast cells and eosinophilic airway infl Clin. Exp. Allerg.y 2016;46:288-297.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Kovanen PT, Bot I. Mast cells in atherosclerotic cardiovascular disease -Activators and actions. Eur. J. Pharmacol. 2017;816:37-46.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Ramirez-Garcia Luna JL, Chan D, Samberg R, Abou-Rjeili M, Wong TH, Li A, Feyerabend TB, Rodewald HR, Henderson JE, Martineau PA. Defective bone repair in mast cell-deficient Cpa3Cre/+ mice. PLoS One. 2017 Mar 28;12(3): e0174396. doi: 10.1371/journal. pone.0174396</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Dellon ES, Selitsky SR, Genta RM, Lash RH, Parker JS. Gene expression-phenotype associations in adults with eosinophilic esophagitis. Dig. Liver Dis. 2018;50:804-811.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Sallis BF, Acar U, Hawthorne K, Babcock SJ, Kanagaratham C, Goldsmith JD, Rosen R, Vanderhoof JA, Nurko S, Fiebiger EA. Distinct Esophageal mRNA Pattern Identifies Eosinophilic Esophagitis Patients with Food Impactions. Front. Immunol. 2018;9:2059.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Fricker M, Gibson PG, Powell H, Simpson JL, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C. A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma. J. Allergy Clin. Immunol. 2019;144:51-60.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Lewicki Ł, Siebert J, Koliński T, Piekarska K, ReiwerGostomska M, Targoński R, Trzonkowski P, Marek-Trzonkowska N. Mast cell derived carboxypeptidase A3 is decreased among patients with advanced coronary artery disease. Cardiol J. 2019;26(6):680-686. doi: 10.5603/CJ.a2018.0018</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Wu B, Tao L, Yang D, Li W, Xu H, He Q. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment. BioMed Res. Int. 2020;1:1-43.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Yan Z, Liu L, Jiao L, Wen X, Liu J, Wang N. Bioinformatics Analysis and Identifi ation of Underlying Biomarkers Potentially Linking Allergic Rhinitis and Asthma. Med. Sci. Monit. 2020;26: e924934.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Collins MH, Martin LJ, Wen T, Abonia JP, Putnam PE, Mukkada VA, Rothenberg ME. Eosinophilic Esophagitis Histology Remission Score: Significant Relations to Measures of Disease Activity and Symptoms. J Pediatr Gastroenterol Nutr. 2020;70(5):598-603. doi: 10.1097/MPG.0000000000002637</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Xu C, Yan S, Guo Y, Qiao L, Ma L, Dou X, Zhang B. Lactobacillus casei ATCC 393 alleviates Enterotoxigenic Escherichia coli K88-induced intestinal barrier dysfunction via TLRs/mast cells pathway. Life Sci. 2020;244:117281. doi: 10.1016/j.lfs.2020.117281.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Winter NA, Gibson PG, McDonald VM, Fricker M. Sputum Gene Expression Reveals Dysregulation of Mast Cells and Basophils in Eosinophilic COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:2165- 2179. doi: 10.2147/COPD.S 305380</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Soria-Castro R, Meneses-Preza YG, Rodríguez-López GM, Romero-Ramírez S, Sosa-Hernández VA, Cervantes-Díaz R, PérezFragoso A, Torres-Ruíz JJ, Gómez-Martín D, Campillo-Navarro M, Álvarez-Jiménez VD, Pérez-Tapia SM, Chávez-Blanco AD, Estrada-Parra S, Maravillas-Montero JL, Chacón-Salinas R. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin. J Leukoc Biol. 2021;110(3):425-431. doi: 10.1002/JLB.4HI0221-087R</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Pejler G, Abrink M, Wernersson S. Serglycin proteoglycan: regulating the storage and activities of hematopoietic proteases. Biofactors. 2009;35(1):61-8. doi: 10.1002/biof.11</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987;138(8):2611-5.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev. 2007;217:141-54. doi: 10.1111/j.1600-065X.2007.00509.x</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Goldstein SM, Kaempfer CE, Kealey JT, Wintroub BU. Human mast cell carboxypeptidase. Purification and characterization. J Clin Invest. 1989;83(5):1630-6. doi: 10.1172/JCI114061</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Reynolds DS, Gurley DS, Austen KF. Cloning and characterization of the novel gene for mast cell carboxypeptidase A. J Clin Invest. 1992;89(1):273-82.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Everitt MT, Neurath H. Rat peritoneal mast cell carboxypeptidase: localization, purification, and enzymatic properties. FEBS Lett. 1980;110:292-296.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Goldstein SM, Kaempfer CE, Proud D, Schwartz LB, Irani AM, Wintroub BU. Detection and partial characterization of a human mast cell carboxypeptidase. J Immunol. 1987;139(8):2724-9. PMID: 2443571.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Cole KR, Kumar S, Trong HL, Woodbury RG, Walsh KA, Neurath H. Rat mast cell carboxypeptidase: amino acid sequence and evidence of enzyme activity within mast cell granules. Biochemistry. 1991;30:648-655.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Reynolds DS, Gurley DS, Stevens RL, Sugarbaker DJ, Austen KF, Serafin WE. Cloning of cDNAs that encode human mast cell carboxypeptidase A, and comparison of the protein with mouse mast cell carboxypeptidase A and rat pancreatic carboxypeptidases. Proc Natl Acad Sci USA. 1989;86(23):9480-4. doi: 10.1073/pnas.86.23.9480</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Reynolds DS, Stevens RL, Gurley DS, Lane WS, Austen KF, Serafin WE. Isolation and molecular cloning of mast cell carboxypeptidase A. A novel member of the carboxypeptidase gene family. J Biol Chem. 1989;264(33):20094-9.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Li L, Li Y, Reddel SW, Cherrian M, Friend DS, Stevens RL, Krilis SA. Identifi ation of basophilic cells that express mast cell granule proteases in the peripheral blood of asthma, allergy, and drugreactive patients. J Immunol. 1998;161(9):5079-86.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Lutzelschwab C, Pejler G, Aveskogh M, Hellman L. Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations. J Exp Med. 1997;185(1):13-29. doi: 10.1084/jem.185.1.13</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Serafi WE, Dayton ET, Gravallese PM, Austen KF, L. Stevens R. Carboxypeptidase A in mouse mast cells: identification, characterization, and use as a differentiation marker. J. Immuno L. 1987;139:3771-3776.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Serafin WE, Sullivan TP, Conder GA, Ebrahimi A, Marcham P, Johnson SS, Austen KF, Reynolds DS. Cloning of the cDNA and gene for mouse mast cell protease 4. Demonstration of its late transcription in mast cell subclasses and analysis of its homology to subclass-specific neutral proteases of the mouse and rat. J Biol Chem. 1991;266(3):1934-41.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>MacDonald AJ, Pick J, Bissonnette EY, Befus AD. Rat mucosal mast cells: the cultured bone marrow-derived mast cell is biochemically and functionally analogous to its counterpart in vivo. Immunology. 1998;93(4):533-9. doi: 10.1046/j.13652567.1998.00465.x</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Weidner N, Austen KF. Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofl determination of chymase, tryptase, and carboxypeptidase content. Pathol Res Pract. 1993;189(2):156-62. doi: 10.1016/S 0344-0338(11)80086-5</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Dougherty RH, Sidhu SS, Raman K, Solon M, Solberg OD, Caughey GH, Woodruff PG, Fahy JV. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J. Allergy Clin. Immunol. 2010;125:1046-1053.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Takabayashi T, Kato A, Peters AT, Suh LA, Carter R, Norton J, Grammer LC, Tan BK, Chandra RK, Conley DB. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J. Allergy Clin. Immunol. 2012;130:410-420.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>Abonia JP, Blanchard C, Butz BB, Rainey HF, Collins MH, Stringer KF, Putnam PE, Rothenberg ME. Involvement of mast cells in eosinophilic esophagitis. J. Allergy Clin. Immunol. 2010;126:140-149.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>Gurish MF, Ghildyal N, McNeil HP, Austen KF, Gillis S, Stevens RL. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand. J Exp Med. 1992;175(4):1003-12. doi: 10.1084/jem.175.4.1003</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>Henningsson F, Hergeth S, Cortelius R, Abrink M, Pejler G. A role for serglycin proteoglycan in granular retention and processing of mast cell secretory granule components. FEBS J. 2006;273(21):4901- 12. doi: 10.1111/j.1742-4658.2006.05489.x.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>Zon LI, Gurish MF, Stevens RL, Mather C, Reynolds DS, Austen KF, Orkin SH. GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J Biol Chem. 1991;266(34):22948-53.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>Dobson JT, Seibert J, Teh EM, Da’as S, Fraser RB, Paw BH, Lin TJ, Berman JN. Carboxypeptidase A5 identifi a novel mast cell lineage in the zebrafi providing new insight into mast cell fate determination. Blood. 2008;112(7):2969-72. doi: 10.1182/ blood-2008-03-145011</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>Morii E, Tsujimura T, Jippo T, Hashimoto K, Takebayashi K, Tsujino K, Nomura S, Yamamoto M, Kitamura Y. Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. Blood. 1996;88(7):2488-94.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>Tchekneva E, Serafin WE. Kirsten sarcoma virusimmortalized mast cell lines. Reversible inhibition of growth by dexamethasone and evidence for the presence of an autocrine growth factor. J. Immunol. 1994;152:5912-5921.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>Eklund KK, Humphries DE, Xia Z, Ghildyal N, Friend DS, Gross V, Stevens RL. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-alpha, and the IL-10-induced expression of chymases. J Immunol. 1997;158(9):4373-80.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>Dvorak AM. Ultrastructure of human mast cells. Int Arch Allergy Immunol. 2002;127(2):100-5.</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>Hammel I, Lagunoff D, Galli SJ. Regulation of secretory granule size by the precise generation and fusion of unit granules. J Cell Mol Med. 2010 Jul;14(7):1904-16. doi: 10.1111/j.15824934.2010.01071.x</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>Robida PA, Puzzovio PG, Pahima H, Levi-Schaffer F, Bochner BS. Human eosinophils and mast cells: Birds of a feather flock together. Immunol Rev. 2018;282(1):151-167. doi: 10.1111/ imr.12638</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>Vukman KV, Försönits A, Oszvald Á, Tóth EÁ, Buzás EI. Mast cell secretome: Soluble and vesicular components. Semin Cell Dev Biol. 2017;67:65-73.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>Arvan P, Castle D. Sorting and storage during secretory granule biogenesis: looking backward and looking forward. Biochem J. 1998;332(Pt3):593-610. doi: 10.1042/bj3320593</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>Blank U. The mechanisms of exocytosis in mast cells. Adv Exp Med Biol. 2011;716:107-22. doi: 10.1007/978-1-4419-9533-9_7.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>De Matteis MA, Luini A. Exiting the Golgi complex. Nat Rev Mol Cell Biol. 2008 Apr;9(4):273-84. doi: 10.1038/nrm2378. PMID: 18354421</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>Hammel I, Lagunoff D, Krüger PG. Studies on the growth of mast cells in rats. Changes in granule size between 1 and 6 months. Lab Invest. 1988;59(4):549-54.</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol. 1989;5:483-525. doi: 10.1146/annurev. cb.05.110189.002411</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>Kolset SO, Tveit H. Serglycin - structure and biology. Cell Mol Life Sci. 2008;65(7-8):1073-85. doi: 10.1007/s00018-007-7455-6.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>Rönnbe rg E , Me l o FR, Pe j l e r G. Ma st c e l l proteoglycans. J Histochem Cytochem. 2012;60(12):950-62. doi: 10.1369/0022155412458927</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>Blank U, Madera-Salcedo IK, Danelli L, Claver J, Tiwari N, Sánchez-Miranda E, Vázquez-Victorio G, Ramírez-Valadez KA, Macias-Silva M, González-Espinosa C. Vesicular traffi king and signaling for cytokine and chemokine secretion in mast cells. Front Immunol. 2014;5:453.</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>Henningsson F, Ledin J, Lunderius C, Wilén M, Hellman L, Pejler G. Altered storage of proteases in mast cells from mice lacking heparin: a possible role for heparin in carboxypeptidase A processing. Biol Chem. 2002;383(5):793-801. doi: 10.1515/BC.2002.083</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>Murakami M, Karnik SS, Husain A. Human prochymase activation. A novel role for heparin in zymogen processing. J Biol Chem. 1995 Feb 3;270(5):2218-23.</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>Abrink M, Grujic M, Pejler G. Serglycin is essential for maturation of mast cell secretory granule. J Biol Chem. 2004;279(39):40897-905. doi: 10.1074/jbc.M405856200</mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation>Atiakshin D, Buchwalow I,·Samoilova V, Tiemann M. Tryptase as a polyfunctional component of mast cells. Histochemistry and Cell Biology. 2018;149(5) 461-477.</mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation>Atiakshin D, Buchwalow I, Tiemann M. Mast cell chymase: morphofunctional characteristics. Histochem Cell Biol. 2019;152(4):253-269. doi: 10.1007/s00418-019-01803-6</mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation>Springman EB, Dikov MM, Serafin WE. Mast cell procarboxypeptidase A. Molecular modeling and biochemical characterization of its processing within secretory granules. J Biol Chem. 1995;270(3):1300-7. doi: 10.1074/jbc.270.3.1300</mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation>Henningsson F. Mast cell cathepsins C and S control levels of carboxypeptidase A and the chymase, mouse mast cell protease 5. Biol. Chem. 2003;384;1527-1531.</mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation>Henningsson F. A role for cathepsin E in the processing of mast-cell carboxypeptidase A.J. Cell Sci. 2005;118:2035-2042.</mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation>Rath-Wolfson L. An immunocytochemical approach to the demonstration of intracellular processing of mast cell carboxypeptidase. Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):81-5.</mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation>Dikov MM, Springman EB, Yeola S, Serafin WE. Processing of procarboxypeptidase A and other zymogens in murine mast cells. J Biol Chem. 1994;269(41):25897-904.</mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation>Schmidt O, Teis D. The ESCRT machinery. Curr Biol. 2012;22(4): R 116-20. doi: 10.1016/j.cub.2012.01.028</mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation>Blair EA, Castle AM, Castle JD. Proteoglycan sulfation and storage parallels storage of basic secretory proteins in exocrine cells. Am J Physiol. 1991;261(5 Pt 1): C 897-905. doi: 10.1152/ ajpcell.1991.261.5.C 897</mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation>Atiakshin DA, Shishkina V V, Gerasimova OA, Meshkova VY, Samodurova NY, Samoilenko TV, Buchwalow IB, Samoilova VE, Tiemann M. Combined histochemical approach in assessing tryptase expression in the mast cell population. Acta Histochem. 2021;123(4):151711. doi: 10.1016/j.acthis.2021.151711</mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation>Kormelink TG, Arkesteijn GJA, van de Lest CHA, Geerts WJC, Goerdayal SS, Altelaar MAF, Redegeld FA, Nolte Hoen ENM, Wauben MHM. Mast Cell Degranulation Is Accompanied by the Release of a Selective Subset of Extracellular Vesicles That Contain Mast Cell- Specifi Proteases. J. Immunol. 2016;197:3382-3392.</mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation>Lecce M, Molfetta R, Milito ND, Santoni A, Paolini R. FcεRI Signaling in the Modulation of Allergic Response: Role of Mast CellDerived Exosomes. Int J Mol Sci. 2020;21(15):5464. doi: 10.3390/ ijms21155464</mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation>Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell. 1997;8(12):2631-45. doi: 10.1091/ mbc.8.12.2631</mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation>Azouz NP, Hammel I, Sagi-Eisenberg R. Characterization of mast cell secretory granules and their cell biology. DNA Cell Biol. 2014;33(10):647-51. doi: 10.1089/dna.2014.2543</mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation>Tiwari N, Wang CC, Brochetta C, Ke G, Vita F, Qi Z, Rivera J, Soranzo MR, Zabucchi G, Hong W, Blank U. VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood. 2008;111(7):3665-74. doi: 10.1182/ blood-2007-07-103309</mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation>Grimberg E, Peng Z, Hammel I, Sagi-Eisenberg R. Synaptotagmin III is a critical factor for the formation of the perinuclear endocytic recycling compartment and determination of secretory granules size. J Cell Sci. 2003;116(Pt 1):145-54. doi: 10.1242/jcs.00186</mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation>Nakazawa S, Sakanaka M, Furuta K, Natsuhara M, Takano H, Tsuchiya S, Okuno Y, Ohtsu H, Nishibori M, Thurmond RL, Hirasawa N, Nakayama K, Ichikawa A, Sugimoto Y, Tanaka S. Histamine synthesis is required for granule maturation in murine mast cells. Eur J Immunol. 2014;44(1):204-14. doi: 10.1002/eji.201343838</mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation>Rickard A, Lagunoff D. Eosinophil peroxidase accounts for most if not all of the peroxidase activity associated with isolated rat peritoneal mast cells. Int Arch Allergy Immunol. 1994;103(4):365-9. doi: 10.1159/000236655. PMID: 7510560.</mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation>Ohtsu H, Kuramasu A, Tanaka S, Terui T, Hirasawa N, Hara M, Makabe-Kobayashi Y, Yamada N, Yanai K, Sakurai E, Okada M, Ohuchi K, Ichikawa A, Nagy A, Watanabe T. Plasma extravasation induced by dietary supplemented histamine in histaminefree mice. Eur J Immunol. 2002;32(6):1698-708. doi: 10.1002/15214141(200206)32:6&lt;1698:: AID-IMMU 1698&gt;3.0.CO;2-7.</mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation>Olszewski MB, Groot AJ, Dastych J, Knol EF. TNF traffi ng to human mast cell granules: mature chain-dependent endocytosis. J Immunol. 2007;178(9):5701-9. doi: 10.4049/ jimmunol.178.9.5701</mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation>Duelli A, Rönnberg E, Waern I, Ringvall M, Kolset SO, Pejler G. Mast cell differentiation and activation is closely linked to expression of genes coding for the serglycin proteoglycan core protein and a distinct set of chondroitin sulfate and heparin sulfotransferases. J Immunol. 2009;183(11):7073-83. doi: 10.4049/jimmunol.0900309</mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation>Moon TC, Befus AD, Kulka M. Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol. 2014;5:569. doi: 10.3389/fimmu.2014.00569</mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation>Feyerabend TB, Hausser H, Tietz A, Blum C, Hellman L, Straus AH, Takahashi HK, Morgan ES, Dvorak AM, Fehling HJ, Rodewald HR. Loss of histochemical identity in mast cells lacking carboxypeptidase A. Mol Cell Biol. 2005;25(14):6199-210. doi: 10.1128/MCB.25.14.6199-6210.2005</mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation>Stevens RL, McNeil HP, Wensing LA, Shin K, Wong GW, Hansbro PM, Krilis SA. Experimental Arthritis Is Dependent on Mouse Mast Cell Protease-5. J Biol Chem. 2017;292(13):5392-5404. doi: 10.1074/jbc.M116.773416</mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation>Dvorak AM, Morgan ES, Lichtenstein L, Weller PF, Schleimer RP. RNA is closely associated with human mast cell secretory granules, suggesting a role(s) for granules in synthetic processes. J Histochem Cytochem. 2000;48:1-12.</mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation>Dvorak AM, Morgan ES. Ribosomes and secretory granules in human mast cells: Close associations demonstrated by staining with a chelating agent. Immunol Rev. 2001;179:94-101.</mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation>Dvorak AM. Ultrastructural studies of human basophils and mast cells. J Histochem Cytochem. 2005;53(9):1043-70. doi: 10.1369/ jhc.5R 6647.2005</mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation>Atiakshin D, Buchwalow I, Horny P, Tiemann M. Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis. Histochem Cell Biol. 2021;155(5):561-580. doi: 10.1007/s00418-021-01964-3</mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation>Craig SS, Schechter NM, Schwartz LB Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest. 1988;58(6):682-91.</mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation>Craig SS, Schechter NM, Schwartz LB. Ultrastructural analysis of maturing human T and TC mast cells in situ. Lab Invest. 1989;60(1):147-57.</mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation>Weidner N, Austen KF. Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. J Invest Dermatol. 1991;96(3 Suppl):26S-30S. doi: 10.1111/1523-1747.ep12468966</mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation>Crivellato E, Beltrami CA, Mallardi F, Ribatti D. The mast cell: an active participant or an innocent bystander? Histol Histopathol. 2004;19(1):259-270.</mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation>De Boer P, Hoogenboom JP, Giepmans BN. Correlated light and electron microscopy: ultrastructure lights up! Nat Methods. 2015;12:503-13.</mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation>Caughey GH. Mast cell proteases as pharmacological targets. Eur J Pharmacol. 2016;778:44-55. doi: 10.1016/j.ejphar.2015.04.045</mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation>Schwartz LB. Localization of carboxypeptidase A to the macromolecular heparin proteoglycan-protein complex in secretory granules of rat serosal mast cells. J. Immunol. 1982;128:1128-1133.</mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation>Goldstein SM, Leong J, Schwartz LB, Cooke D. Protease composition of exocytosed human skin mast cell protease-proteoglycan complexes. Tryptase resides in a complex distinct from chymase and carboxypeptidase. J Immunol. 1992;148(8):2475-82.</mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation>Schwartz LB, Riedel C, Caulfield JP, Wasserman SI, Austen KF. Cell association of complexes of chymase, heparin proteoglycan, and protein after degranulation by rat mast cells. J Immunol. 1981;126(6):2071-8.</mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation>Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullberg M, Eriksson I, Ledin J, Hellman L, Kjellén L. Abnormal mast cells in mice defi in a heparin-synthesizing enzyme. Nature. 1999;400(6746):773-6. doi: 10.1038/23488</mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation>Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, Huang C, Sharpe AH, Stevens RL. Heparin is essential for the storage of specifi granule proteases in mast cells. Nature. 1999;400(6746):769-72. doi: 10.1038/23481</mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation>Dvorak AM, McLeod RS, Onderdonk A, MonahanEarley RA, Cullen JB, Antonioli DA, Morgan E, Blair JE, Estrella P, Cisneros RL. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol. 1992;99(1):74-83.</mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation>Xu H, Bin NR, Sugita S. Diverse exocytic pathways for mast cell mediators. Biochem Soc Trans. 2018;46(2):235-247.</mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation>Crivellato E, Nico B, Mallardi F, Beltrami CA, Ribatti D. Piecemeal degranulation as a general secretory mechanism? Anat Rec A Discov Mol Cell Evol Biol. 2003;274(1):778-84.</mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation>Williams RM, Webb WW. Single granule pH cycling in antigen-induced mast cell secretion. J Cell Sci. 2000;113 Pt 21:3839-50.</mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation>Atiakshin D, Buchwalow I, Tiemann M. Mast cells and collagen fibrillogenesis. Histochem Cell Biol. 2020 Jul;154(1):21-40.</mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation>Veerappan A, Thompson M, Savage AR, Silverman ML, Chan WS, Sung B, Summers B, Montelione KC, Benedict P, Groh B, Vicencio AG, Peinado H, Worgall S, Silver RB, Mast cells and exosomes in hyperoxia-induced neonatal lung disease. Am J Physiol Lung Cell Mol Physiol. 2016;310(11): L1218-32.</mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation>Atiakshin D, Samoilova V, Buchwalow I, Boecker W, Tiemann M. Characterization of mast cell populations using different methods for their identifi Histochem Cell Biol. 2017;147(6):683-694.</mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation>Melo FR, Wallerman O, Paivandy A, Calounova G, Gustafson AM, Sabari BR, Zabucchi G, Allis CD, Pejler G. Tryptasecatalyzed core histone truncation: A novel epigenetic regulatory mechanism in mast cells. J Allergy Clin Immunol. 2017;140(2):474-485.</mixed-citation></ref><ref id="B128"><label>128.</label><mixed-citation>Alanazi S, Grujic M, Lampinen M, Rollman O, Sommerhoff CP, Pejler G, Melo FR. Mast Cell beta-Tryptase Is Enzymatically Stabilized by DNA. Int J Mol Sci. 2020;21(14):5065. doi: 10.3390/ijms21145065</mixed-citation></ref><ref id="B129"><label>129.</label><mixed-citation>Alanazi S, Rabelo Melo F and Pejler G Tryptase Regulates the Epigenetic Modification of Core Histones in Mast Cell Leukemia Cells. Front. Immunol. 2021;12:804408. doi: 10.3389/ fimmu.2021.804408</mixed-citation></ref><ref id="B130"><label>130.</label><mixed-citation>Kunder CA, St John AL, Li G, Leong KW, Berwin B, Staats HF, Abraham SN. Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med. 2009;206(11):2455-67.</mixed-citation></ref><ref id="B131"><label>131.</label><mixed-citation>Puri N, Roche PA. Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc. Natl Acad. Sci. USA. 2008;105:2580-2585.</mixed-citation></ref><ref id="B132"><label>132.</label><mixed-citation>Mulloy B, Lever R Page CP. Mast cell glycosaminoglycans. Glycoconjugate journal. 2017;34(3):351-361.</mixed-citation></ref><ref id="B133"><label>133.</label><mixed-citation>Metz M, Piliponsky AM, Chen CC, Lammel V, Abrink M, Pejler G, Tsai M, Galli SJ. Mast cells can enhance resistance to snake and honeybee venoms. Science. 2006;313(5786):526-30. doi: 10.1126/ science.1128877</mixed-citation></ref><ref id="B134"><label>134.</label><mixed-citation>Rivera J. Snake bites and bee stings: the mast cell strikes back. Nat Med. 2006;12(9):999-1000. doi: 10.1038/nm0906-999</mixed-citation></ref><ref id="B135"><label>135.</label><mixed-citation>Asai S, Sato T, Tada T, Miyamoto T, Kimbara N, Motoyama N, Okada H, Okada N. Absence of procarboxypeptidase R induces complement-mediated lethal inflammation in lipopolysaccharide-primed mice. J Immunol. 2004;173(7):4669-74. doi: 10.4049/jimmunol.173.7.4669</mixed-citation></ref><ref id="B136"><label>136.</label><mixed-citation>Sanglas L, Aviles FX, Huber R, Gomis-Rüth FX, Arolas JL. Mammalian metallopeptidase inhibition at the defense barrier of Ascaris parasite. Proc Natl Acad Sci U S A. 2009;106(6):1743-7. doi: 10.1073/ pnas.0812623106</mixed-citation></ref><ref id="B137"><label>137.</label><mixed-citation>Maurer M, Wedemeyer J, Metz M, Piliponsky AM, Weller K, Chatterjea D, Clouthier DE, Yanagisawa MM, Tsai M, Galli SJ. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nat. Cell Biol. 2004;432:512-516.</mixed-citation></ref><ref id="B138"><label>138.</label><mixed-citation>Pejler G. The emerging role of mast cell proteases in asthma. Eur Respir J. 2019;54(4):1900685. doi: 10.1183/13993003.00685-2019</mixed-citation></ref><ref id="B139"><label>139.</label><mixed-citation>Owens EP, Vesey DA, Kassianos AJ, Healy H, Hoy WE, Gobe GC. Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease. Transl Androl Urol. 2019;8(Suppl2): S 175-S 183. doi: 10.21037/tau.2018.11.03.</mixed-citation></ref><ref id="B140"><label>140.</label><mixed-citation>Magnúsdóttir EI, Grujic M, Bergman J, Pejler G, Lagerström MC. Mouse connective tissue mast cell proteases tryptase and carboxypeptidase A3 play protective roles in itch induced by endothelin-1. J Neuroinflammation. 2020;17(1):123. doi: 10.1186/ s12974-020-01795-4</mixed-citation></ref><ref id="B141"><label>141.</label><mixed-citation>Hültner L, Ehrenreich H. Mast cells and endothelin-1: A life-saving biological liaison? Trends Immunol. 2005;26:235-238.</mixed-citation></ref><ref id="B142"><label>142.</label><mixed-citation>Reddanna P, Prabhu KS, Whelan J, Reddy CC. Carboxypeptidase A-catalyzed direct conversion of leukotriene C 4 to leukotriene F4. Arch Biochem Biophys. 2003;413(2):158-63. doi: 10.1016/s0003-9861(03)00080-8</mixed-citation></ref><ref id="B143"><label>143.</label><mixed-citation>Goldstein SM, Leong J, Bunnett NW. Human mast cell proteases hydrolyze neurotensin, kinetensin and Leu5-enkephalin. Peptides. 1991;12(5):995-1000. doi: 10.1016/0196-9781(91)90049-u</mixed-citation></ref><ref id="B144"><label>144.</label><mixed-citation>Bunnett NW, Goldstein SM, Nakazato P. Isolation of a neuropeptide-degrading carboxypeptidase from the human stomach. Gastroenterology. 1992;102(1):76-87. doi: 10.1016/00165085(92)91786-4</mixed-citation></ref><ref id="B145"><label>145.</label><mixed-citation>Cochrane DE, Carraway RE, Boucher W, Feldberg RS. Rapid degradation of neurotensin by stimulated rat mast cells. Peptides. 1991;12(6):1187-94. doi: 10.1016/0196-9781(91)90193-s</mixed-citation></ref><ref id="B146"><label>146.</label><mixed-citation>Piliponsky AM, Chen CC, Nishimura T, Metz M, Rios EJ, Dobner PR, Wada E, Wada K, Zacharias S, Mohanasundaram UM, Faix JD, Abrink M, Pejler G, Pearl RG, Tsai M, Galli SJ. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med. 2008;14(4):392-8. doi: 10.1038/nm1738</mixed-citation></ref><ref id="B147"><label>147.</label><mixed-citation>Kokkonen JO, Vartiainen M, Kovanen PT. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A. J Biol Chem. 1986;261(34):16067-72.</mixed-citation></ref><ref id="B148"><label>148.</label><mixed-citation>Abe M, Kurosawa M, Ishikawa O, Miyachi Y. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fi proliferation and type I collagen production. J Allergy Clin Immunol. 2000;106(1Pt2): S 78-84. doi: 10.1067/mai.2000.106058</mixed-citation></ref><ref id="B149"><label>149.</label><mixed-citation>Dell’Italia LJ, Collawn J, Ferrario CM. Multifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling. Circ Res. 2018;122:319-336.</mixed-citation></ref><ref id="B150"><label>150.</label><mixed-citation>Okamoto Y, Takai S, Miyazaki M. Significance of chymase inhibition for prevention of adhesion formation. Eur. J. Pharmacol. 2004;484:357-359.</mixed-citation></ref><ref id="B151"><label>151.</label><mixed-citation>Balzar S, Fajt ML, Comhair SA, Erzurum SC, Bleecker E, Busse WW, Castro M, Gaston B, Israel E, Schwartz LB, CurranEverett D, Moore CG, Wenzel SE. Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. Am J Respir Crit Care Med. 2011;183(3):299-309. doi: 10.1164/rccm.201002-0295OC</mixed-citation></ref><ref id="B152"><label>152.</label><mixed-citation>Lill M, Kõks S, Soomets U, Schalkwyk LC, Fernandes C, Lutsar I, Taba P. Peripheral blood RNA gene expression profi in patients with bacterial meningitis. Front Neurosci. 2013;7:33. doi: 10.3389/fnins.2013.00033</mixed-citation></ref><ref id="B153"><label>153.</label><mixed-citation>Mikus MS, Kolmert J, Andersson LI, Östling J, Knowles RG, Gómez C, Ericsson M, Thörngren JO, Khoonsari PE, Dahlén B, Kupczyk M, De Meulder B, Auffray C, Bakke PS, Beghe B, Bel EH, Caruso M, Chanez P, Chawes B, Fowler SJ, Gaga M, Geiser T, Gjomarkaj M, Horváth I, Howarth PH, Johnston SL, Joos G, Krug N, Montuschi P, Musial J, Niżankowska-Mogilnicka E, Olsson HK, Papi A, Rabe KF, Sandström T, Shaw DE, Siafakas NM, Uhlen M, Riley JH, Bates S, Middelveld RJM, Wheelock CE, Chung KF, Adcock IM, Sterk PJ, Djukanovic R, Nilsson P, Dahlén SE, James A; U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease outcome) Study Group; BIOAIR (Longitudinal Assessment of Clinical Course and Biomarkers in Severe Chronic Airway Disease) Consortium. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation. Eur Respir J. 2021 Nov 4:2100142. doi: 10.1183/13993003.00142-2021</mixed-citation></ref></ref-list></back></article>
